Asset Details
Do you wish to reserve the book?
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Do you wish to request the book?
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
2020
Overview
Background & objectives: The global pandemic caused by SARS-CoV-2 virus has challenged public health system worldwide due to the unavailability of approved preventive and therapeutic options. Identification of neutralizing antibodies (NAb) and understanding their role is important. However, the data on kinetics of NAb response among COVID-19 patients are unclear. To understand the NAb response in COVID-19 patients, we compared the findings of microneutralization test (MNT) and plaque reduction neutralization test (PRNT) for the SARS-CoV-2. Further, the kinetics of NAb response among COVID-19 patients was assessed.
Methods: A total of 343 blood samples (89 positive, 58 negative for SARS-CoV-2 and 17 cross-reactive and 179 serum from healthy individuals) were collected and tested by MNT and PRNT. SARS-CoV-2 virus was prepared by propagating the virus in Vero CCL-81 cells. The intra-class correlation was calculated to assess the correlation between MNT and PRNT. The neutralizing endpoint as the reduction in the number of plaque count by 90 per cent (PRNT90) was also calculated.
Results: The analysis of MNT and PRNT quantitative results indicated that the intra-class correlation was 0.520. Of the 89 confirmed COVID-19 patients, 64 (71.9%) showed NAb response.
Interpretation & conclusions: The results of MNT and PRNT were specific with no cross-reactivity. In the early stages of infection, the NAb response was observed with variable antibody kinetics. The neutralization assays can be used for titration of NAb in recovered/vaccinated or infected COVID-19 patients.
Publisher
Wolters Kluwer India Pvt. Ltd,Medknow Publications and Media Pvt. Ltd,Scientific Scholar,Wolters Kluwer - Medknow
Subject
/ Adult
/ Animals
/ Antibodies, Neutralizing - immunology
/ Antibodies, Neutralizing - isolation & purification
/ Betacoronavirus - immunology
/ Betacoronavirus - pathogenicity
/ Child
/ Chlorocebus aethiops - immunology
/ Coronavirus Infections - blood
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - immunology
/ Coronavirus Infections - virology
/ COVID-19
/ Female
/ Humans
/ Male
/ Original
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - immunology
